This suggests that ARBs may possess prophylactic and therapeutic effects in PCa, given that proliferation of prostate cells is mediated by angiotensin II, and ARBs through suppression of MAPK or STAT3 phosphorylation [49]. The gene discussed is STAT3; the disease is posterior cortical atrophy.